CUV 6.00% $14.58 clinuvel pharmaceuticals limited

Ann: Revenue Growth Drives CLINUVEL's Full Year Profit, page-6

  1. 2,117 Posts.
    lightbulb Created with Sketch. 260
    Great post @MPolo spot on, and from todays webinar comments they have independent report results stating they are only 2/3% of EPP patients in the USA so much potential profit and cash flows.

    Franked dividends from here out plus lots planned for 2023 *DJ Clinuvel MD: FY 2023 Will Become Year of Transformational Expansion

    Jefferies has just upped the price target to $36.90 from $31.40 hence todays rise
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.